Faith L. Charles's Net Worth
$89.7 Thousand
Who is Faith L. Charles?
Faith L. Charles does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ABEONA THERAPEUTICS INC., AVENUE THERAPEUTICS, INC., CNS Pharmaceuticals, Inc., and CONDUIT PHARMACEUTICALS INC..
SEC CIK
Faith L. Charles's CIK is 0001853985
Past Insider Trading and Trends
2023 was Faith L. Charles's most active year for acquiring shares with 5 total transactions. Faith L. Charles's most active month to acquire stocks was the month of August. 2023 was Faith L. Charles's most active year for disposing of shares, totalling 1 transactions. Faith L. Charles's most active month to dispose stocks was the month of August. 2023 saw Faith L. Charles paying a total of $629,293.18 for 295,978 shares, this is the most they've acquired in one year. In 2023 Faith L. Charles cashed out on 8,330 shares for a total of $40,923.62, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ABEONA THERAPEUTICS INC. (ABEO) Snapshot price: $4.52
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.67% | 7.55K |
$3.28 | $24,764.00 | 78.32K |
Apr 26
| |||
Form 4
| -10.53% | -8.33K |
$4.91 | -$40,923.62 | 70.77K |
Sep 27
| |||
Form 4
| +287.49% | 58.69K |
$4.62 | $271,143.18 | 79.1K |
Jun 14
| |||
Form 4
| +191.05% | 13.4K |
—
|
—
| 20.41K |
Sep 26
| |||
Form 4
|
∞
| 77.18K |
—
|
—
| 77.18K |
May 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVENUE THERAPEUTICS, INC. (ATXI) Snapshot price: $0.1223
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CNS Pharmaceuticals, Inc. (CNSP) Snapshot price: $0.2922
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 8
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||